RE:Wesana Health psychedelic research, founder X-NHL’rSUBSEQUENT EVENTS On February 2, 2021, the Company announced that it had entered into a binding agreement (the “Agreement”) with WeSana Health Inc. (“Wesana”) to complete a business combination by way of a reverse takeover transaction of the Company by Wesana (the “Transaction”). The Transaction will be structured as an amalgamation, arrangement, takeover bid, share purchase or other similar form of transaction or a series of transactions that have a similar effect with the Company acquiring all shares of Wesana. The resulting issuer (the “Resulting Issuer”) that will exist upon completion of the Transaction will change its business from mining to the health sciences industry. Pursuant to the Agreement, the Company will effect a consolidation of its issued and outstanding common shares prior to the completion of the Transaction that will result in the shareholders (including warrant holders) of the Company receiving shares that have a value of US$1.5 million. Prior to the completion of the Transaction, the Company will call a meeting of its shareholders for the purpose of approving matters required to give effect to the Transaction, including: name change, share consolidation, the creation of a new class of super voting shares, the creation of a new class of multiple voting shares, the reconstitution of the Resulting Issuer’s board of directors, and approval of the Transaction by the CSE, if required. Upon closing, the Company’s current directors and executive officers will resign, and the board of directors and executive officers of the Resulting Issuer will be comprised of the nominees of Wesana. As a condition to closing the Transaction, Wesana, or a newly formed special purpose financing vehicle, will complete a brokered private placement of subscription receipts.